PT102931A - Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapia intestinal - Google Patents

Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapia intestinal

Info

Publication number
PT102931A
PT102931A PT10293103A PT10293103A PT102931A PT 102931 A PT102931 A PT 102931A PT 10293103 A PT10293103 A PT 10293103A PT 10293103 A PT10293103 A PT 10293103A PT 102931 A PT102931 A PT 102931A
Authority
PT
Portugal
Prior art keywords
atpase
blockers
activities
utilization
exchange
Prior art date
Application number
PT10293103A
Other languages
English (en)
Other versions
PT102931B (pt
Inventor
Patricio Soares Da Silva
Original Assignee
Univ Do Porto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Do Porto filed Critical Univ Do Porto
Priority to PT102931A priority Critical patent/PT102931B/pt
Priority to PCT/PT2004/000005 priority patent/WO2004084886A1/en
Publication of PT102931A publication Critical patent/PT102931A/pt
Publication of PT102931B publication Critical patent/PT102931B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT102931A 2003-03-28 2003-03-28 Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapiaintestinal PT102931B (pt)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PT102931A PT102931B (pt) 2003-03-28 2003-03-28 Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapiaintestinal
PCT/PT2004/000005 WO2004084886A1 (en) 2003-03-28 2004-03-26 THE USE OF BLOCKERS FOR THE LONG-TERM INHIBITION OF Na+-K+-ATPase AND/OR Na+/H+ EXCHANGE ACTIVITIES FOR THE PREPARATION OF A MEDICAMENT FOR THE INTESTINAL THERAPY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT102931A PT102931B (pt) 2003-03-28 2003-03-28 Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapiaintestinal

Publications (2)

Publication Number Publication Date
PT102931A true PT102931A (pt) 2004-09-30
PT102931B PT102931B (pt) 2005-08-31

Family

ID=33095907

Family Applications (1)

Application Number Title Priority Date Filing Date
PT102931A PT102931B (pt) 2003-03-28 2003-03-28 Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapiaintestinal

Country Status (2)

Country Link
PT (1) PT102931B (pt)
WO (1) WO2004084886A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2468741A1 (en) * 2010-12-16 2012-06-27 Bel/Novamann International s.r.o. Novel quercetin derivatives, their preparation, pharmaceutical compositions containing them and their use
TW202120074A (zh) * 2019-11-29 2021-06-01 財團法人醫藥工業技術發展中心 對羥基苯甲醛於治療發炎性腸道疾病的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61238728A (ja) * 1985-04-16 1986-10-24 Mitsui Norin Kk 茶葉抽出物と活性水酸化アルミニウムとの抗潰瘍性複合体
JPH0778021B2 (ja) * 1988-04-13 1995-08-23 太陽化学株式会社 下痢症ウイルス感染阻害剤
US5318986A (en) * 1989-10-19 1994-06-07 Mitsui Norin Co., Ltd. Method of inhibiting the activity of α-amylase
JP3108483B2 (ja) * 1991-09-30 2000-11-13 日清製粉株式会社 インドール誘導体およびこれを有効成分とする抗潰瘍薬
JP3002919B2 (ja) * 1991-11-25 2000-01-24 太陽化学株式会社 胃炎，胃または十二指腸潰瘍防止組成物
US5605929A (en) * 1992-05-27 1997-02-25 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
US5391568A (en) * 1992-07-10 1995-02-21 American Health Foundation Inhibition of lung tumorigenesis by administration of a polyphenol
US5670154A (en) * 1994-01-10 1997-09-23 Mitsui Norin Co., Ltd. Reducing tyrosinase activity
JPH08217674A (ja) * 1995-02-16 1996-08-27 Noda Sangyo Kagaku Kenkyusho ヒスチジン脱炭酸酵素阻害剤
DE19627344A1 (de) * 1996-07-01 1998-01-08 Vitasyn Gmbh Entwicklung & Ver Therapeutisch wirksame bzw. gesundheitsfördernde Zubereitung aus definierten Polyphenolverbindungen
JPH11116475A (ja) * 1997-10-07 1999-04-27 Snow Brand Milk Prod Co Ltd 炎症性腸疾患予防及び／又は治療剤
JPH11193239A (ja) * 1997-12-26 1999-07-21 Itouen Ltd ガストリン分泌抑制剤及び胃酸分泌抑制剤
US5922756A (en) * 1998-02-14 1999-07-13 Chan; Marion Man-Ying Method of inhibiting nitric oxide synthase
SE9900473D0 (sv) * 1999-02-12 1999-02-12 Karolinska Innovations Ab Inhibitor of endothelial cell proliferation
AU4043900A (en) * 1999-03-30 2000-10-16 Purdue Research Foundation Compositions containing tea catechins as cancer specific proliferation inhibitors
US6248341B1 (en) * 2000-01-14 2001-06-19 Color Access, Inc. Method of treating topical angiogenesis-related disorders
KR100379323B1 (ko) * 2000-02-29 2003-04-08 삼아약품 주식회사 카테킨을 포함하는 관상동맥 재협착 예방 및 치료용 약학조성물
ITRM20010600A1 (it) * 2001-10-04 2003-04-04 Brane Tech S R L Composti flavonoidici capaci di modificare lo stato fisico e/o dinamico di membrane biologiche e di stimolare la sintesi endogena di protein

Also Published As

Publication number Publication date
WO2004084886A1 (en) 2004-10-07
PT102931B (pt) 2005-08-31

Similar Documents

Publication Publication Date Title
FR20C1005I1 (fr) Solution de chlorure de sodium pour la reconstitution de medicaments
TWI318981B (en) Novel thiophene glycoside derivatives, processes for their preparation , medicaments comprising these compounds, and the use thereof
DK1592457T3 (da) Folat-vinblastin-konjugat som lægemiddel
IL180108A (en) Sulfamate and Sulfamide Derivatives, Pharmaceutical Preparations Containing Them, Processes for their Preparation
DK1307457T3 (da) Azabicycliske forbindelser, deres fremstilling og deres anvendelse som medikamenter, især som antibakterielle midler
BRPI0411547B1 (pt) composiÇço de tratamento na lavagem de roupa.
NO20054220D0 (no) Substituerte N-arylheterocykler, fremgangsmate for fremstilling derav og deres anvendelse som legemiddel
BRPI0313399A2 (pt) terapia de troca de plasma seletiva
ATE537831T1 (de) Orale aripiprazol-lösung
FR2867064B1 (fr) Doseur de medicaments
IL173527A0 (en) Pharmaceutical composition containing water soluble drug
PT1379220E (pt) Capsulas de inalacao
IL175749A0 (en) Chaperone - based therapy for niemann-pick disease
DE602004017428D1 (de) Texturiertes, eine behandlungszusammensetzung enthaltendes gewebe
GB0324627D0 (en) Redundant gaming system
NO20042158L (no) Substituert 4-fenyl-tetrahydroisokinoliner, fremgangsmate for fremstilling derav, anvendelse derav som medikamenter, i tillegg til medikamenter inneholdende samme
NO20022801D0 (no) Substituerte norbornylaminoderivater, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikumsåvel som medikamenter inneholdende disse
IL173004A0 (en) Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments
ATE345776T1 (de) Osmotisches verabreichungssystem
PT102931A (pt) Utilizacao de bloqueadores da inibicao a longo termo das actividades da atpase na+k+e/ou do trocador na+/h+, na preparacao de um medicamento destinado a terapia intestinal
NO20016430D0 (no) Farmasöytisk kompleks
EP1674088A4 (en) Grape-based preparation containing a biguaneid drug
AU2003223686A8 (en) Immunogenic agent therapy using plasmapheresis or exchange transfusion
NO20052593D0 (no) Kontinuerlig fremgangsmate for fremstilling av fruktopyranose sulfamat derivater.
FR2869319B1 (fr) Gel concentre en polyester sulfonique ramifie et procede de preparation de ce gel

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20030529

FG3A Patent granted, date of granting

Effective date: 20030328

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20070928

NF4A Restitutio in integrum

Free format text: RESTITUTIO IN INTEGRUM

Effective date: 20080806